載入...

Comparative studies of guanfacine and methyldopa

1 The antihypertensive effects of the new phenylacetylguanidine compound, guanfacine, a sympathetic inhibitor with a central site of action, were compared with methyldopa in 20 out-patients with essential or renal hypertension (WHO grade I-II). 2 During a 6-week period in randomized cross-over condi...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Roeckel, A., Heidland, A.
格式: Artigo
語言:Inglês
出版: 1980
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC1430116/
https://ncbi.nlm.nih.gov/pubmed/6994779
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!